Neurosarcoidosis associated with interferon therapy.
Miwa
H
H
Department of Neurology, Juntendo University Urayasu Hospital, Urayasu City, Chiba, Japan. h_miwa@med.jutendo.ac.jp
Furuya
T
T
Tanaka
S
S
Mizuno
Y
Y
D000284:Administration, Oral; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000627:therapeutic use; D000998:Antiviral Agents / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use*; D005260:Female; D019698:Hepatitis C, Chronic / Q000188:drug therapy*; D006801:Humans; D007273:Injections, Intramuscular; D016899:Interferon-beta / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use*; D008875:Middle Aged; D009422:Nervous System Diseases / Q000139:chemically induced* / Q000188:drug therapy*; D011239:Prednisolone / Q000008:administration & dosage / Q000627:therapeutic use; D012507:Sarcoidosis / Q000139:chemically induced / Q000188:drug therapy*
D000893:Anti-Inflammatory Agents; D000998:Antiviral Agents; D016899:Interferon-beta; D011239:Prednisolone